PeptideDB

SID-852843 909859-19-4

SID-852843 909859-19-4

CAS No.: 909859-19-4

SID-852843 is a WNV NS2B-NS3 protease inhibitor. SID-852843 can inhibit WNV NS2B-NS3 protease activity with IC50 of 0.10
Data collection:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

SID-852843 is a WNV NS2B-NS3 protease inhibitor. SID-852843 can inhibit WNV NS2B-NS3 protease activity with IC50 of 0.105 μM. SID-852843 can be used for research on viral infections.

Physicochemical Properties


Molecular Formula C17H15N3O5S
Molecular Weight 373.38
Exact Mass 373.073
Elemental Analysis C, 54.69; H, 4.05; N, 11.25; O, 21.42; S, 8.59
CAS # 909859-19-4
PubChem CID 655490
Appearance Off-white to light yellow solid powder
LogP 3.592
Hydrogen Bond Donor Count 1
Hydrogen Bond Acceptor Count 7
Rotatable Bond Count 6
Heavy Atom Count 26
Complexity 580
Defined Atom Stereocenter Count 0
InChi Key FQICFDBMQBCJDT-UHFFFAOYSA-N
InChi Code

InChI=1S/C17H15N3O5S/c1-24-13-7-9-14(10-8-13)26(22,23)20-15(18)11-16(19-20)25-17(21)12-5-3-2-4-6-12/h2-11H,18H2,1H3
Chemical Name

[5-amino-1-(4-methoxyphenyl)sulfonylpyrazol-3-yl] benzoate
Synonyms

909859-19-4; MLS000033898; ML024; SID-852843
HS Tariff Code 2934.99.9001
Storage

Powder-20°C 3 years

4°C 2 years

In solvent -80°C 6 months

-20°C 1 month

Shipping Condition Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)

Biological Activity


ln Vitro SID-852843 has an IC50 value of 0.105 μM, which is sufficient to block WNV NS2B-NS3 protease activity[1].
References

[1]. Structure-activity relationship and improved hydrolytic stability of pyrazole derivatives that are allosteric inhibitors of West Nile Virus NS2B-NS3 proteinase. Bioorg Med Chem Lett. 2009 Oct 1;19(19):5773-7.

Additional Infomation Benzoic acid [5-amino-1-(4-methoxyphenyl)sulfonyl-3-pyrazolyl] ester is a benzoate ester.

Solubility Data


Solubility (In Vitro) DMSO : 100 mg/mL (267.82 mM)
Solubility (In Vivo) Solubility in Formulation 1: ≥ 2.5 mg/mL (6.70 mM) (saturation unknown) in 10% DMSO + 40% PEG300 +5% Tween-80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 + to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL.
Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution.

 (Please use freshly prepared in vivo formulations for optimal results.)
Preparing Stock Solutions 1 mg 5 mg 10 mg
1 mM 2.6782 mL 13.3912 mL 26.7824 mL
5 mM 0.5356 mL 2.6782 mL 5.3565 mL
10 mM 0.2678 mL 1.3391 mL 2.6782 mL
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.